Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis.

Journal of public health management and practice : JPHMP

Roche LM, Niu X, Stroup AM, Henry KA.
PMID: 28430705
J Public Health Manag Pract. 2017 Sep/Oct;23(5):477-486. doi: 10.1097/PHH.0000000000000524.

BACKGROUND: Despite improvements in early detection of breast cancer, disparities persist in stage at diagnosis, which is an important prognostic factor.METHODS: We used the space-time scan statistic in SaTScan to identify geographic areas and time periods with significantly elevated...

Cite
Roche LM, Niu X, Stroup AM, et al. Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis. J Public Health Manag Pract. 2017;23(5):477-486doi: 10.1097/PHH.0000000000000524.
Roche, L. M., Niu, X., Stroup, A. M., & Henry, K. A. (2017). Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis. Journal of public health management and practice : JPHMP, 23(5), 477-486. https://doi.org/10.1097/PHH.0000000000000524
Roche, Lisa M, et al. "Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis." Journal of public health management and practice : JPHMP vol. 23,5 (2017): 477-486. doi: https://doi.org/10.1097/PHH.0000000000000524
Roche LM, Niu X, Stroup AM, Henry KA. Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis. J Public Health Manag Pract. 2017 Sep/Oct;23(5):477-486. doi: 10.1097/PHH.0000000000000524. PMID: 28430705; PMCID: PMC5548504.
Copy Download .nbib Format: NLM
Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Wang X, Su YR, Petersen PS, Bien S, Schmit SL, Drew DA, Albanes D, Berndt SI, Brenner H, Campbell PT, Casey G, Chang-Claude J, Gallinger SJ, Gruber SB, Haile RW, Harrison TA, Hoffmeister M, Jacobs EJ, Jenkins MA, Joshi AD, Li L, Lin Y, Lindor NM, Marchand LL, Martin V, Milne R, Maclnnis R, Moreno V, Nan H, Newcomb PA, Potter JD, Rennert G, Rennert H, Slattery ML, Thibodeau SN, Weinstein SJ, Woods MO, Chan AT, White E, Hsu L, Peters U.
PMID: 32651213
Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1800-1808. doi: 10.1158/1055-9965.EPI-19-1018. Epub 2020 Jul 10.

BACKGROUND: Regular use of nonsteroidal anti-inflammatory drugs (NSAID) is associated with lower risk of colorectal cancer. Genome-wide interaction analysis on single variants (G × E) has identified several SNPs that may interact with NSAIDs to confer colorectal cancer risk,...

Cite
Wang X, Su YR, Petersen PS, et al. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020;29(9):1800-1808doi: 10.1158/1055-9965.EPI-19-1018.
Wang, X., Su, Y. R., Petersen, P. S., Bien, S., Schmit, S. L., Drew, D. A., Albanes, D., Berndt, S. I., Brenner, H., Campbell, P. T., Casey, G., Chang-Claude, J., Gallinger, S. J., Gruber, S. B., Haile, R. W., Harrison, T. A., Hoffmeister, M., Jacobs, E. J., Jenkins, M. A., Joshi, A. D., Li, L., Lin, Y., Lindor, N. M., Marchand, L. L., Martin, V., Milne, R., Maclnnis, R., Moreno, V., Nan, H., Newcomb, P. A., Potter, J. D., Rennert, G., Rennert, H., Slattery, M. L., Thibodeau, S. N., Weinstein, S. J., Woods, M. O., Chan, A. T., White, E., Hsu, L., & Peters, U. (2020). Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 29(9), 1800-1808. https://doi.org/10.1158/1055-9965.EPI-19-1018
Wang, Xiaoliang, et al. "Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 29,9 (2020): 1800-1808. doi: https://doi.org/10.1158/1055-9965.EPI-19-1018
Wang X, Su YR, Petersen PS, Bien S, Schmit SL, Drew DA, Albanes D, Berndt SI, Brenner H, Campbell PT, Casey G, Chang-Claude J, Gallinger SJ, Gruber SB, Haile RW, Harrison TA, Hoffmeister M, Jacobs EJ, Jenkins MA, Joshi AD, Li L, Lin Y, Lindor NM, Marchand LL, Martin V, Milne R, Maclnnis R, Moreno V, Nan H, Newcomb PA, Potter JD, Rennert G, Rennert H, Slattery ML, Thibodeau SN, Weinstein SJ, Woods MO, Chan AT, White E, Hsu L, Peters U. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1800-1808. doi: 10.1158/1055-9965.EPI-19-1018. Epub 2020 Jul 10. PMID: 32651213; PMCID: PMC7556991.
Copy Download .nbib Format: NLM
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Qin B, Babel RA, Plascak JJ, Lin Y, Stroup AM, Goldman N, Ambrosone CB, Demissie K, Hong CC, Bandera EV, Llanos AAM.
PMID: 33234556
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):344-350. doi: 10.1158/1055-9965.EPI-20-1055. Epub 2020 Nov 24.

BACKGROUND: The disproportionate burden of more aggressive breast cancer subtypes among African American/Black women may stem from multilevel determinants. However, data are limited regarding the impacts of neighborhood social environmental characteristics among Black women.METHODS: We evaluated the association between...

Cite
Qin B, Babel RA, Plascak JJ, et al. Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women. Cancer Epidemiol Biomarkers Prev. 2020;30(2):344-350doi: 10.1158/1055-9965.EPI-20-1055.
Qin, B., Babel, R. A., Plascak, J. J., Lin, Y., Stroup, A. M., Goldman, N., Ambrosone, C. B., Demissie, K., Hong, C. C., Bandera, E. V., & Llanos, A. A. M. (2021). Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(2), 344-350. https://doi.org/10.1158/1055-9965.EPI-20-1055
Qin, Bo, et al. "Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,2 (2021): 344-350. doi: https://doi.org/10.1158/1055-9965.EPI-20-1055
Qin B, Babel RA, Plascak JJ, Lin Y, Stroup AM, Goldman N, Ambrosone CB, Demissie K, Hong CC, Bandera EV, Llanos AAM. Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women. Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):344-350. doi: 10.1158/1055-9965.EPI-20-1055. Epub 2020 Nov 24. PMID: 33234556; PMCID: PMC7867587.
Copy Download .nbib Format: NLM
Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Peprah S, Engels EA, Horner MJ, Monterosso A, Hall HI, Johnson AS, Pfeiffer RM, Shiels MS.
PMID: 34162660
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1627-1633. doi: 10.1158/1055-9965.EPI-21-0008. Epub 2021 Jun 23.

BACKGROUND: The introduction of combination antiretroviral therapy (cART) has led to a significant reduction in Kaposi sarcoma (KS) incidence among people with HIV (PWH). However, it is unclear if incidence has declined similarly across key demographic and HIV transmission...

Cite
Peprah S, Engels EA, Horner MJ, et al. Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1627-1633doi: 10.1158/1055-9965.EPI-21-0008.
Peprah, S., Engels, E. A., Horner, M. J., Monterosso, A., Hall, H. I., Johnson, A. S., Pfeiffer, R. M., & Shiels, M. S. (2021). Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1627-1633. https://doi.org/10.1158/1055-9965.EPI-21-0008
Peprah, Sally, et al. "Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1627-1633. doi: https://doi.org/10.1158/1055-9965.EPI-21-0008
Peprah S, Engels EA, Horner MJ, Monterosso A, Hall HI, Johnson AS, Pfeiffer RM, Shiels MS. Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1627-1633. doi: 10.1158/1055-9965.EPI-21-0008. Epub 2021 Jun 23. PMID: 34162660; PMCID: PMC8419027.
Copy Download .nbib Format: NLM
Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Peprah S, Engels EA, Horner MJ, Monterosso A, Hall HI, Johnson AS, Pfeiffer RM, Shiels MS.
PMID: 34162660
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1627-1633. doi: 10.1158/1055-9965.EPI-21-0008. Epub 2021 Jun 23.

BACKGROUND: The introduction of combination antiretroviral therapy (cART) has led to a significant reduction in Kaposi sarcoma (KS) incidence among people with HIV (PWH). However, it is unclear if incidence has declined similarly across key demographic and HIV transmission...

Cite
Peprah S, Engels EA, Horner MJ, et al. Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1627-1633doi: 10.1158/1055-9965.EPI-21-0008.
Peprah, S., Engels, E. A., Horner, M. J., Monterosso, A., Hall, H. I., Johnson, A. S., Pfeiffer, R. M., & Shiels, M. S. (2021). Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1627-1633. https://doi.org/10.1158/1055-9965.EPI-21-0008
Peprah, Sally, et al. "Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1627-1633. doi: https://doi.org/10.1158/1055-9965.EPI-21-0008
Peprah S, Engels EA, Horner MJ, Monterosso A, Hall HI, Johnson AS, Pfeiffer RM, Shiels MS. Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1627-1633. doi: 10.1158/1055-9965.EPI-21-0008. Epub 2021 Jun 23. PMID: 34162660; PMCID: PMC8419027.
Copy Download .nbib Format: NLM
Solid Organ Transplantation and Survival among Individuals with a History of Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM.
PMID: 33926864
Cancer Epidemiol Biomarkers Prev. 2021 Jul;30(7):1312-1319. doi: 10.1158/1055-9965.EPI-21-0044. Epub 2021 Apr 29.

BACKGROUND: The success of immunotherapy highlights a possible role for immunity in controlling cancer during remission for patients with cancer in the general population. A prior cancer diagnosis is common among solid organ transplant candidates, and immunosuppressive medications administered...

Cite
Engels EA, Haber G, Hart A, et al. Solid Organ Transplantation and Survival among Individuals with a History of Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(7):1312-1319doi: 10.1158/1055-9965.EPI-21-0044.
Engels, E. A., Haber, G., Hart, A., Lynch, C. F., Li, J., Pawlish, K. S., Qiao, B., Yu, K. J., & Pfeiffer, R. M. (2021). Solid Organ Transplantation and Survival among Individuals with a History of Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(7), 1312-1319. https://doi.org/10.1158/1055-9965.EPI-21-0044
Engels, Eric A, et al. "Solid Organ Transplantation and Survival among Individuals with a History of Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,7 (2021): 1312-1319. doi: https://doi.org/10.1158/1055-9965.EPI-21-0044
Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM. Solid Organ Transplantation and Survival among Individuals with a History of Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Jul;30(7):1312-1319. doi: 10.1158/1055-9965.EPI-21-0044. Epub 2021 Apr 29. PMID: 33926864; PMCID: PMC8254777.
Copy Download .nbib Format: NLM
Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Gallicchio L, Elena JW, Fagan S, Carter M, Hamilton AS, Hastert TA, Hunter LL, Li J, Lynch CF, Milam J, Millar MM, Modjeski D, Paddock LE, Reed AR, Moses LB, Stroup AM, Sweeney C, Trapido EJ, West MM, Wu XC, Helzlsouer KJ.
PMID: 32651214
Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1699-1709. doi: 10.1158/1055-9965.EPI-20-0153. Epub 2020 Jul 10.

BACKGROUND: While the primary role of central cancer registries in the United States is to provide vital information needed for cancer surveillance and control, these registries can also be leveraged for population-based epidemiologic studies of cancer survivors. This study...

Cite
Gallicchio L, Elena JW, Fagan S, et al. Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study. Cancer Epidemiol Biomarkers Prev. 2020;29(9):1699-1709doi: 10.1158/1055-9965.EPI-20-0153.
Gallicchio, L., Elena, J. W., Fagan, S., Carter, M., Hamilton, A. S., Hastert, T. A., Hunter, L. L., Li, J., Lynch, C. F., Milam, J., Millar, M. M., Modjeski, D., Paddock, L. E., Reed, A. R., Moses, L. B., Stroup, A. M., Sweeney, C., Trapido, E. J., West, M. M., Wu, X. C., & Helzlsouer, K. J. (2020). Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 29(9), 1699-1709. https://doi.org/10.1158/1055-9965.EPI-20-0153
Gallicchio, Lisa, et al. "Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 29,9 (2020): 1699-1709. doi: https://doi.org/10.1158/1055-9965.EPI-20-0153
Gallicchio L, Elena JW, Fagan S, Carter M, Hamilton AS, Hastert TA, Hunter LL, Li J, Lynch CF, Milam J, Millar MM, Modjeski D, Paddock LE, Reed AR, Moses LB, Stroup AM, Sweeney C, Trapido EJ, West MM, Wu XC, Helzlsouer KJ. Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study. Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1699-1709. doi: 10.1158/1055-9965.EPI-20-0153. Epub 2020 Jul 10. PMID: 32651214; PMCID: PMC7484198.
Copy Download .nbib Format: NLM
The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Mahale P, Shiels MS, Lynch CF, Chinnakotla S, Wong LL, Hernandez BY, Pawlish KS, Li J, Alverson G, Schymura MJ, Engels EA.
PMID: 33199438
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):513-520. doi: 10.1158/1055-9965.EPI-20-1188. Epub 2020 Nov 16.

BACKGROUND: Hepatocellular carcinoma (HCC) carries a poor prognosis. Liver transplantation (LT) is potentially curative for localized HCC. We evaluated the impact of LT on U.S. general population HCC-specific mortality rates.METHODS: The Transplant Cancer Match Study links the U.S. transplant...

Cite
Mahale P, Shiels MS, Lynch CF, et al. The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States. Cancer Epidemiol Biomarkers Prev. 2020;30(3):513-520doi: 10.1158/1055-9965.EPI-20-1188.
Mahale, P., Shiels, M. S., Lynch, C. F., Chinnakotla, S., Wong, L. L., Hernandez, B. Y., Pawlish, K. S., Li, J., Alverson, G., Schymura, M. J., & Engels, E. A. (2021). The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(3), 513-520. https://doi.org/10.1158/1055-9965.EPI-20-1188
Mahale, Parag, et al. "The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,3 (2021): 513-520. doi: https://doi.org/10.1158/1055-9965.EPI-20-1188
Mahale P, Shiels MS, Lynch CF, Chinnakotla S, Wong LL, Hernandez BY, Pawlish KS, Li J, Alverson G, Schymura MJ, Engels EA. The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States. Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):513-520. doi: 10.1158/1055-9965.EPI-20-1188. Epub 2020 Nov 16. PMID: 33199438; PMCID: PMC8052263.
Copy Download .nbib Format: NLM
Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors.

Preventive medicine reports

Manne SL, Heckman CJ, Kashy D, Lozada C, Gallo J, Ritterband L, Coups EJ.
PMID: 32461880
Prev Med Rep. 2020 May 01;19:101110. doi: 10.1016/j.pmedr.2020.101110. eCollection 2020 Sep.

Melanoma patients are at elevated risk for recurrence of the primary cancer as well as second primary melanomas. Regular skin self-examination (SSE) is recommended as part of follow-up surveillance. In this study, we examined SSE performance and comprehensiveness as...

Cite
Manne SL, Heckman CJ, Kashy D, et al. Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors. Prev Med Rep. 2020;19:101110doi: 10.1016/j.pmedr.2020.101110.
Manne, S. L., Heckman, C. J., Kashy, D., Lozada, C., Gallo, J., Ritterband, L., & Coups, E. J. (2020). Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors. Preventive medicine reports, 19101110. https://doi.org/10.1016/j.pmedr.2020.101110
Manne, Sharon L, et al. "Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors." Preventive medicine reports vol. 19 (2020): 101110. doi: https://doi.org/10.1016/j.pmedr.2020.101110
Manne SL, Heckman CJ, Kashy D, Lozada C, Gallo J, Ritterband L, Coups EJ. Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors. Prev Med Rep. 2020 May 01;19:101110. doi: 10.1016/j.pmedr.2020.101110. eCollection 2020 Sep. PMID: 32461880; PMCID: PMC7240727.
Copy Download .nbib Format: NLM
Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women's circle of Health Study.

Environmental research

Rao R, McDonald JA, Barrett ES, Greenberg P, Teteh DK, Montgomery SB, Qin B, Lin Y, Hong CC, Ambrosone CB, Demissie K, Bandera EV, Llanos AAM.
PMID: 34390715
Environ Res. 2022 Jan;203:111863. doi: 10.1016/j.envres.2021.111863. Epub 2021 Aug 11.

BACKGROUND: Building upon our earlier findings of significant associations between hair dye and relaxer use with increased breast cancer risk, we evaluated associations of select characteristics of use with breast tumor clinicopathology.METHODS: Using multivariable-adjusted models we examined the associations...

Cite
Rao R, McDonald JA, Barrett ES, et al. Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women's circle of Health Study. Environ Res. 2021;203:111863doi: 10.1016/j.envres.2021.111863.
Rao, R., McDonald, J. A., Barrett, E. S., Greenberg, P., Teteh, D. K., Montgomery, S. B., Qin, B., Lin, Y., Hong, C. C., Ambrosone, C. B., Demissie, K., Bandera, E. V., & Llanos, A. A. M. (2022). Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women's circle of Health Study. Environmental research, 203111863. https://doi.org/10.1016/j.envres.2021.111863
Rao, Rohan, et al. "Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women's circle of Health Study." Environmental research vol. 203 (2022): 111863. doi: https://doi.org/10.1016/j.envres.2021.111863
Rao R, McDonald JA, Barrett ES, Greenberg P, Teteh DK, Montgomery SB, Qin B, Lin Y, Hong CC, Ambrosone CB, Demissie K, Bandera EV, Llanos AAM. Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women's circle of Health Study. Environ Res. 2022 Jan;203:111863. doi: 10.1016/j.envres.2021.111863. Epub 2021 Aug 11. PMID: 34390715; PMCID: PMC8616798.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries